| Name | NMN |
| Synonyms | β-Nicotinamide mononucleotide |
| CAS | 1094-61-7 |
| EINECS | 214-136-5 |
| Formula | C11H16N2O8P |
| Molar Mass | 334.22 |
| Density | |
| Melting Point | 166 °C(dec.) |
| Boiling Point | |
| Flash Point | |
| Water Solubility | DMSO (Slightly, Heated), Methanol (Slightly), Water (Slightly) |
| Vapor Pressure | |
| Refractive Index | |
| Specific Rotation | |
| Use | After NMN administration, there was no difference in blood glucose levels in i.p. GTTs between Nampt+/- and control female mice. In addition, NMN-treated Nampt+/- and control mice also had similar plasma insulin levels at each time point. These data clearly indicate that NMN administration corrects the defect in GSIS observed in Nampt+/- mice.
|
| Physical and Chemical Properties | White powder |
| Safety Description | |
| Risk Codes | |
| Hazard Symbols |